Advice
in the absence of a submission from the holder of the marketing authorisation.
etoricoxib (Arcoxia) is not recommended for use within NHSScotland for the treatment of ankylosing spondylitis.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice51KB (PDF)
Medicine details
- Medicine name:
- etoricoxib (Arcoxia)
- SMC ID:
- 576/09
- Indication:
- ankylosing spondylitis.
- Pharmaceutical company
- MSD
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 07 September 2009